Abstract
The diagnosis of medication overuse headache (MOH) is clinically important, because patients rarely respond to preventive medications whilst overusing acute medications. Properly treating medication overuse and preventing relapse require recognition of the different factors that contribute to its development and perpetuation, including some behaviours and psychological elements that are important in sustaining the overuse of medication. This article reviews current clinical experiences of MOH patients treated with different approaches. Moreover, initial outcomes and long-term durability of treatments are discussed.
Sommario
La diagnosi di Medication-Overuse Headache è impegnativa e presenta implicazioni clinico-terapeutiche importanti poiché questa categoria di pazienti difficilmente risponde alle terapie di profilassi comunemente usate nei pazienti emicranici. Un trattamento adeguato ed una attenta prevenzione delle recidive di abuso richiedono una valutazione dei diversi fattori di rischio che contribuiscono allo sviluppo e alla degenerazione delle forme emicraniche episodiche in forme croniche. Anche i fattori psicologici e comportamentali sono riconosciuti come determinanti per la induzione del “Medication-Overuse”. In questo lavoro vengono descritte diverse esperienze cliniche condotte in pazienti affette da forme emicraniche cronicizzate e Medication-Overuse; sono descritti i diversi approcci terapeutici e le possibili strategie terapeutiche a partire dalla “disassuefazione” da sintomatici alla impostazione di una eventuale profilassi. Sono inoltre menzionati e discussi i risultati derivanti dalle diverse esperienze cliniche con relativi follow-up.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24[Suppl 1]
Headache Classification Subcommittee of the International Headache Society (1988) The International Classification of Headache Disorders. Cephalalgia 8[Suppl 7]:1–96
Grazzi L, Andrasik F (2006) Medication-overuse headache: description, treatment, and relapse prevention. Curr Pain Headache Rep 10:71–77
Diener HC, Limmroth V (2004) Medication overuse headache: a worldwide problem. Lancet Neurol 3:475–483
Lu SR, Fuh JL, Chen WT et al (2001) Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21:980–986
Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190–196
Wang SJ, Fuh JL, Lu SR (2000) Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 54:314–319
Hershey AD (2003) Chronic daily headache in children. Expert Opin Pharmacother 4:485–491
Grazzi L, Andrasik F (2006) Medication-overuse headache: description, treatment, and relapse prevention. Curr Pain Headache Rep 10:71–77
Lake III AE, Rains JC, Penzien DB, Lipchik GL (2005) Headache and psychiatric comorbidity: historical context, clinical implications and research relevance. Headache 45:493–506
Scher AJ, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of Chronic Daily Headache in a population-based study. Pain 106:81–89
Siniatchkin M, Riabus M, Hasenbring M (1999) Coping styles of headache sufferers. Cephalalgia 19:165–173
Meng ID, Cao L (2007) From migraine to chronic daily headache: the biological basis of headache transformation. Headache 47:1251–1258
Penzien DB, Rains JC, Lipchik GL et al (2005) Future directions in behavioral headache research: applications for an evolving healthcare environment. Headache 45:526–534
Lake A III (2006) Medication overuse headache: biobehavioral issues and solutions. Headache 46[Suppl 3]:89–97
Meletiche DM, Lofland JH, Young WB (2001) Quality of life differences between patients with episodic and transformed migraine. Headache 42:573–578
D’Amico D, Usai S, Grazzi L (2003) Quality of life and disability in primary chronic daily headaches. Neurol Sci 24:S97–S100
Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine and cluster headache with topiramate. Headache 42:796–803
Grazzi L, Andrasik F, D’Amico D et al (2004) Disability in chronic migraine patients with medication overuse: treatment effects at 1 year follow-up. Headache 44:678–683
Stewart WF, Lipton RB, Whyte J et al (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994
D’Amico D, Mosconi P, Genco S et al (2001) The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947–952
Andrasik F, Lipchik GL, McCrory DC, Wittrock DA (2005) Outcome measurement in behavioral headache research: headache parameters and psychosocial outcomes. Headache 45:429–437
Freitag F, Lake AL III, Lipton R et al (2004) Inpatient treatment of headache: an evidence-based assessment. Headache 44:342–360
Diener HC, Dichgans J, Scholz E et al (1989) Analgesicinduced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9–14
Dodick DW (2002) Analgesic overuse is not a cause of chronic daily headache. Headache 42:547–554
Rapoport A, Weeks R, Sheftell F (1985) Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K (eds) Proceedings Second International Headache Congress, Copenhagen, pp 448–449
Bigal M, Rapoport A, Sheftell FD et al (2004) Transformed migraine and medication overuse in a tertiary headache center — clinical characteristics and treatment outcome. Cephalalgia 24:483–490
Andrasik F, Grazzi L, Usai S et al (2007) Disability in chronic migraine with medication overuse: treatment effect at 3 years. Headache 47:1277–1281
Diener HC, Mathew NT (2000) Drug induced headache. In: Diener HC (ed) Drug treatment of migraine and other frequent headaches, Vol. 17. Karger Press, Basel, pp 347–356
Mathew NT, Kurman R, Perez F (1990) Drug-induced refractory headache: clinical features and management. Headache 30:634–638
Katsarava Z, Fritsche G, Muessig M et al (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57:1694–1698
Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z et al (2007) Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 27:1219–1225
Krymchantowski AV, Barbosa JS (2000) Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 20:107–113
Raskin NH (1986) Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 36:995–997
Mathew NT (1987) Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 27:205–209
Diener HC, Haab J, Peters C et al (1990) Subcutaneous sumatriptan in treatment of headache during withdrawal from drug-induced headache. Headache 31:205–209
Suhr B, Evers S, Bauer B et al (1999) Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19:44–49
Krymchantowski AV, Moreira PF (2003) Outpatient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23:982–993
Hering R, Steiner TJ (1991) Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 337:1442–1443
Pini LA, Bigarelli M, Vitale G, Sternieri E (1996) Headaches associated with chronic use of analgesic. A therapeutic approach. Headache 36:433–439
Usai S, Grazzi L, Andrasik A et al (2007) Inpatient vs day hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: preliminary results at 2 year follow-up. Neurol Sci 28[Suppl 2]:S242
Grazzi L, Andrasik F, D’Amico D et al (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42:483–490
Andrasik F (2003) Behavioural treatment approaches to chronic headache. Neurol Sci 24:S80–S85
Lake III AE, Saper J, Madden S, Kreeger C (1993) Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study. Headache 33:55–62
Holroyd KA, Powers SW, Andrasik F (2005) Methodological issues in clinical trials of drug and behavior therapies. Headache 45:487–492
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grazzi, L., Andrasik, F., Usai, S. et al. Headache with medication overuse: treatment strategies and proposals of relapse prevention. Neurol Sci 29, 93–98 (2008). https://doi.org/10.1007/s10072-008-0867-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-0867-8